Bank’s Apothecary strives to be at the forefront of the latest therapies in healthcare. Part of our mission is to gain access to LDDs (limited distribution drugs). LDDs are medications located and dispensed in highly specialized pharmacies proven to give the best level of patient care. Once a pharmacy can demonstrate they have met the highest expectations of the industry, drug manufacturers will grant access to dispense those therapies.
Bank’s Apothecary continuously strives to enhance its LDD profile to ensure our patients have access to the newest therapies on the cutting edge of healthcare.
Today Bank’s is proud to announce that we have been selected to dispense the groundbreaking drug Aimovig.
More About Aimovig
The United States Food and Drug Administration approved the medication for the preventive treatment of migraine headaches in adults. Aimovig targets the calcitonin gene-related peptide receptor (CGRPR) for the prevention of migraines.
We are always working to make sure our patients have the BEST quality healthcare possible. We thank you for your continued trust in our service to you.
On the same day, Bank’s Apothecary was also trusted by the industry to become a distributor of another LDD, Olumiant.